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The final step in carnitine biosynthesis is catalyzed
by g-butyrobetaine (gBB) hydroxylase (BBOX), an
iron/2-oxoglutarate (2OG) dependent oxygenase.
BBOX is inhibited by trimethylhydrazine-propionate
(THP), a clinically used compound. We report struc-
tural and mechanistic studies on BBOX and its
reaction with THP. Crystallographic and sequence
analyses reveal that BBOX and trimethyllysine
hydroxylase form a subfamily of 2OG oxygenases
that dimerize using anN-terminal domain. The crystal
structure reveals the active site is enclosed and how
THP competes with gBB. THP is a substrate giving
formaldehyde (supporting structural links with
histone demethylases), dimethylamine, malonic
acid semi-aldehyde, and an unexpected product
with an additional carbon-carbon bond resulting
from N-demethylation coupled to oxidative rear-
rangement, likely via an unusual radical mechanism.
The results provide a basis for development of
improved BBOX inhibitors and may inspire the
discovery of additional rearrangement reactions.
INTRODUCTION
In animals, many plants and microorganisms carnitine (L-3-
hydroxy-4-N,N,N-trimethylaminobutyrate, CAR) plays an essen-
tial metabolic role by enabling transport of long-chain fatty acids
into the mitochondria. CAR is also involved in transport of the
products of b oxidation, fatty acid storage, excretion of toxic
products, and maintaining acyl-coenzyme-A/coenzyme-A ho-
meostasis (Vaz and Wanders, 2002). In animals CAR is obtained
from the diet and by endogenous biosynthesis. CAR is used as
food supplement to promote fatty acid metabolism and is
produced either in racemic form by synthesis or in chiral form
by fermentation (Naidu et al., 2000; Brass et al., 1994).
In animals CAR biosynthesis occurs from N3-trimethyllysine,
which is produced by hydrolysis of methylated proteins (Fig-
ure 1A). Pioneering work demonstrated that two CAR biosyn-1316 Chemistry & Biology 17, 1316–1324, December 22, 2010 ª2010thesis steps are catalyzed by Fe(II) and 2-oxoglutarate (2OG)
dependent oxygenases, N3-trimethyllysine hydroxylase (TMLH)
and g-butyrobetaine (gBB) hydroxylase (BBOX). (Hulse et al.,
1978; Lindstedt, 1967, 1977; Englard et al., 1985). BBOX is the
target for 3-(2,2,2-trimethylhydrazine)propionate (THP), which
is used to treat myocardial infarction (Simkhovich et al., 1988;
Dambrova et al., 2002). THP is proposed to lower the levels of
reactive oxidizing species associated with fatty acid metabolism
by preventing CAR-mediated transport.
We report structural and mechanistic analyses on human
BBOX and its inhibition by THP. The results reveal a close
relationship between BBOX and TMLH and link the CAR biosyn-
thesis enzymes with the 2OG-dependent histone N3-methyl
lysine demethylases. Studies with gBB analogs and on the
mechanism of action of THP reveal that BBOX can catalyze
N-methyl demethylation and that the reaction of THP with
BBOX involves an unprecedented rearrangement involving
N-methyl cleavage and a novel C-C bonding forming reaction.
RESULTS
Characterization of BBOX Activity
To investigate its relationshipwith other human 2OGoxygenases
and the mechanism of action of THP, we produced recombinant
human BBOX and developed an NMR assay (Figure 1B). The
results reveal human BBOX to be highly active and dependent
on Fe(II) (see Figure S1A and Table S1A, entry I, available online)
and show CAR production to be tightly coupled to 2OG oxida-
tion. BBOX activity was stimulated by potassium ions and
reducing agents, including but not limited to ascorbate, and
subject to substrate inhibition (Figure S1A), as observed with
prokaryotic and partially purified animal BBOX (Lindstedt et al.,
1977; Wehbie et al., 1988). The observations with reducing
agents are consistent with mouse model work using animals
that cannot produce ascorbate (Furusawa et al., 2008).
Overall Structure
We crystallized BBOX employing Zn(II) as an Fe(II) substitute and
N-oxalylglycine (NOG, an unreactive 2OG analog) (Table S1B,
entry I) and gBB. The resultant BBOX.Zn.NOG.gBB structure
(resolution 1.82 A˚) reveals a homodimer as observed in solution
analyses (Galland et al., 1998; Krissinel and Henrick, 2007) (Fig-
ure 2). Each monomer comprises N- and C-terminal domainsElsevier Ltd All rights reserved
Figure 1. The Role of BBOX in CAR Biosynthesis
(A) The carnitine biosynthesis pathway.
(B) NMRmonitoring of BBOX activity in real time: signals for L-Carnitine (CAR), gBB, 2OG, and succinate. Spectra are at 10-min intervals, and the first spectrum is
recorded 5 min after sample mixing.
See also Figure S1 for more BBOX characterization.
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Crystal Structure of g-Butyrobetaine Hydroxylaselinked by a-helix a3 (residue range 97–110), positioned close to
the C-terminal helix (a10). The N-terminal domain (comprised
of secondary elements a1, a2, b1–8) enables dimerization.
Whereas dimerization via C-terminal structural elements has
been observed for other 2OG oxygenases, BBOX represents
the first example of dimerization via an N-terminal domain.
Sequence analyses imply that TMLH similarly dimerizes via its
N-terminal domain (Figure S2i). The presence of a zinc-binding
site in the N-terminal domain was unexpected and is formed
by a 3Cys-1His zinc-binding motif (Cys38, Cys40, Cys43, and
His82). The C-terminal domain has a double-stranded b-helical
core fold (DSBH, bI–bVIII) (Figure 2) forming the major (b11I,
b22VIII, b13III, b20VI, b10, b9) and minor (b12II, b21VII, b14IV,
b19V) b sheets, characteristic of 2OG oxygenases (Clifton
et al., 2006). A 94 residue ‘‘insert’’ between DSBH strands
b14IV and b19V contains three a helices (a7, a8, a9), four
b strands (b15, b16, b17, b18), and one 310 helix (3104). This insert
folds over the more open end of the DSBH, forming both part of
the active site and part of the dimerization interface with the
N-terminal domain of the other chain in the dimer. A loop and
a 310-helix (3103) links DSBH strand b11
I with strand b12II. This
region (residues 184–198) also folds over the active site and is
involved in substrate binding (Figure 2B); in addition, it interacts
with another region comprised of the antiparallel b strands b4-b5
and helix 3102 (residues 43–54), which extends from the
N-terminal domain zinc-binding site of the other chain in the
dimer. Sequence comparison of BBOXwith TMLH (26% identity)
implies that both the folds and active sites of the two enzymes
are similar.
N-Terminal Zinc-Binding Domain
The N-terminal domain fold of BBOX is most related to that of
a protein of unknown function fromAcidithiobacillus ferrooxidans
ATCC 23270 (PDB ID 3LUU; PFAM family DUF971, PF06155;
DALI Z score = 10.8; rmsd 2.1 A˚ over 81 residues), which has
many homologs (including in prokaryotes), though none other
than BBOX or TMLH appear to be 2OG oxygenases. The
3Cys-1His zinc-binding motif is conserved in many of theChemistry & Biology 17, 1316–132apparent homologs (Figure S2ii). Although the equivalent
N-terminal domain zinc-binding residues in the Acidithiobacillus
protein structure appear partially disordered, it does have zinc
bound, albeit using residues from different secondary structural
elements (His36, Glu40, and the C-terminal carboxylate of
Glu100). Cys-40 of BBOX is substituted with serine in TMLH,
potentially altering metal-binding specificity in TMLH (Figures
S2i and S2ii).
Active Site
The active site is enclosed by loops between b11I–b12II,
b18–3104, and b strand b15 (Figure 3). The opening of a tunnel
leading toward the active site, which may enable binding of
oxygen and release of CO2, is ‘‘bridged’’ by the side chains of
Val-192 (located between b11I–b12II) and Ala-294 (located
between b18–3104) (Figure 3C). The small size of the tunnel
opening suggests that conformational changes by loop move-
ments may occur to enable substrate binding and product
release.
As for other 2OG oxygenases (Clifton et al., 2006), the active
site metal is bound by three ligands (His-202, Asp-204, and
His-347) (Figure 3). NOGbinds to themetal in a bidentatemanner
with its 1-carboxylate coordinating via a single oxygen (trans
to His-347) and its C-2 carbonyl oxygen (trans to Asp-204).
The C-5 carboxylate of NOG interacts with a basic residue
(Arg-360) and a hydroxyl group (Ser-229), as observed in other
2OG oxygenases; untypically a second arginine (Arg-349) is
also involved in binding of the 2OG C-5 carboxylate. A water
completes the octahedral coordination sphere and is positioned
to form a hydrogen bondwith Gln-215O3 (2.7 A˚) and the Asp-204
carboxylate (2.8 A˚), suggesting that both of these residues play
a role in O2 binding. The remainder of the residues around the
putative O2-binding site are hydrophobic (Trp-181, Leu-217,
Leu-362). The metal coordination site closest to C-3 of the
substrate is occupied by the 2OG C-1 carboxylate. Although it
is uncertain whether the crystal structure reflects the solution
situation, this arrangement suggests that O2 may bind at the
position occupied by the water, necessitating a rearrangement4, December 22, 2010 ª2010 Elsevier Ltd All rights reserved 1317
Figure 2. The Overall Fold of BBOX
(A) Stereo view ribbons representation of
the BBOX:Zn:NOG:gBB structure. Colored and
labeledbysecondarystructureelements;bstrands
are pink, and the core DSBH strands are high-
lighted in yellow, a helices are light blue, and loops
are white. Metal binding residues are shown as
white sticks, the Zn(II) is displayed as an orange
sphere (substituting for iron at the active site) and
as a gray sphere in the N-terminal domain. NOG
is shown as yellow sticks and gBB as green sticks.
(B) Ribbons representation of the BBOX dimer;
one monomer is in pink and the other colored as
in (A) except for the N-terminal Zn(II) binding
domain in light green and the b14IV-b19V insert,
which is purple in both molecules.
See also Figure S2 for human BBOX sequence
alignments.
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Crystal Structure of g-Butyrobetaine Hydroxylase(as proposed for other 2OG oxygenases) (Zhang et al., 2002) for
the catalytically reactive ferryl intermediate (Hausinger, 2004;
Hoffart et al., 2006) to be positioned adjacent to the oxidized
bond. gBB binds adjacent to the metal, such that its C-3 pro-R
C-H bond, which must undergo hydroxylation to give CAR,
projects toward the metal (C-3 gBB to metal: 4.7 A˚) (Englard
et al., 1985) (Figure 3B).
Substrate Specificity
The gBB carboxylate is positioned to interact via hydrogen
bonds with the side chains of Asn-292 (2.9 A˚), Asn-191 (2.9 A˚),
and the backbone amide of Tyr-205 (2.9 A˚) (Figures 3A and
3B). Structurally informed sequence analyses imply that1318 Chemistry & Biology 17, 1316–1324, December 22, 2010 ª2010 Elsevier Ltd All rights reBBOX and TMLH bind their substrates
similarly, except that a modification
(Asn191BBOX to Asp131TMLH) at the
observed C-1 gBB carboxylate-binding
site of BBOX enables binding of the
a amino group of TMLH’s N3-trimethylly-
sine substrate (Figures S2i and S2iii).
The positively charged gBBN-trimethyl
ammonium group is located in an elec-
tron-rich aromatic ‘‘cage’’ formed by the
side chains of Tyr177, Tyr-194, and
Trp-181 (Figures 3B; Figure S3i) with the
side chains of two other aromatic resi-
dues positioned nearby (Tyr-205 and
Tyr-366). Tyr-366 is also positioned to
hydrogen bond to the side chain of
Asp-204, suggesting that it may be
involved in coordinating gBB binding
and reactions at the metal center. The
mode of binding of the N-trimethyl group
is strikingly similar to the manner in which
the same group binds to plant homeobox
domain and Tudor domains that bind to
modified histones (Huang et al., 2006;
Horton et al., 2010) (Figure S3i). N-tri-
methyl binding also occurs with the
2OG-dependent histone N3-lysyl deme-thylases; however, with these enzymes the N-trimethyl binding
site is less hydrophobic because one of the substrate methyl
groups must be adjacent to the iron to enable demethylation
(Ng et al., 2007).
Structural Insights into Specificity
and Enzymatic Mechanism
Support for the crystallographically observed substrate binding
mode was obtained from substrate analog studies. The carbox-
ylate functionality is an absolute requirement for substrate
binding and activity (data not shown), but the requirement for
the trimethylamino group is less stringent. gBB analogs with
deletion or addition of a methylene group were substrates forserved
Figure 3. BBOX Active Site
(A) Stereo view representation of the electron density (2Fo-Fc electron density map shown as gray mesh contoured to 1s) from the 1.82 A˚ resolution BBOX:gBB
structure data. The metal is shown as an orange sphere that is coordinated by three BBOX residues (shown as white sticks), a water (red sphere), and
N-oxalylglycine (yellow sticks). gBB is shown as green sticks. Black dashes indicate metal coordination and selected hydrogen bonds.
(B) View of the active site of BBOX in complex with Zn(II) (orange sphere), N-oxalylglycine (yellow sticks), and gBB (green sticks). Interactions between the gBB
carboxylate and Asn-191, Asn-292 and metal coordination interactions are indicated by black dashes. Asn-191 also plays a role in capping the 310 helix (3103)
indicated by a dashed line to the backbone amide of Ala-193.
(C) Solvent accessible surface of BBOX (gray and blue) showing the opening of the tunnel bridged by residues Val-192 and Ala-294. The tunnel leads to the active
site and is lined by Val-192, Ala-294, Ala-293, Asn-191, Thr-295, Leu-199 (shown as blue surface and sticks).
See also Figure S3 for BBOX ligand binding and a comparison of the BBOX and histone lysine demethylase active sites.
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Crystal Structure of g-Butyrobetaine HydroxylaseBBOX but were oxidized less efficiently (Table S1A, entries II and
III, respectively), as was the gBB analog with two N3-methyl
groups (Table S1A, entry IV).
Analysis of the gBB-binding site revealed the side chain
hydrogen bond donor/acceptor atom of Asn-191 is 3.8 A˚ from
the C-3 carbon of gBB (Figure 3), suggesting that BBOX may
accept substrates having a polar group at C-3 with ‘‘D’’ stereo-
chemistry; therefore, we tested the D-enantiomer of CAR
(D-CAR) as a substrate for BBOX. We found that D-CAR was
a substrate for BBOX (Table S1A, entry V) producing N,N,N-tri-
methylaminoacetone, presumably through facile nonenzymatic
decarboxylation of an intermediate b carboxyketone formed
from the C-3 dihydroxylated product (Figure S4i). Interestingly,
we also found that with extended incubation times, CAR itself
was a substrate, albeit poorer than gBB or D-CAR, and like theChemistry & Biology 17, 1316–132latter producing N,N,N-trimethylaminoacetone (Table S1A, entry
VI). From a biological perspective these observations are of
interest because trimethylaminoacetone has been described
as a metabolite of racemic carnitine or D-CAR (Holme et al.,
1982). These results rationalize a previous study whereby
increased 2OG turnover was observed when D-, L-, or racemic
carnitine was reacted with partially purified BBOX from human
kidney and pseudomonas sp. AK1 (Bremer, 1983). Thus, meta-
bolic production of N,N,N-trimethylaminoacetone could be
minimized by using pure L-carnitine (CAR), rather than racemic
carnitine, as a dietary supplement.
Inhibitor Complex
To investigate its mechanism of action, we then solved a struc-
ture of THP in complex with BBOX (1.82 A˚ resolution). The overall4, December 22, 2010 ª2010 Elsevier Ltd All rights reserved 1319
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Crystal Structure of g-Butyrobetaine Hydroxylasestructure revealed that despite the substitution of an amino
group for the C-4 methylene of gBB, THP occupies a near-
identical position compared to gBB (Figure S3i). The Tyr-366
phenolic OH is positioned to interact with the secondary amino
group of THP (3.6 A˚). Notably, as for gBB, the THP C-3 pro-R
hydrogen projects toward the metal, suggesting that THP may
act as a competitive substrate (THP IC50 34 mM) (Table S1B,
entry II).
Rearrangement Mechanism
Initial NMR studies on the reaction of THP with BBOX demon-
strated that the inhibitor acts as a substrate with the same
cofactor requirement as gBB (Table S1A, entry VII), as suggested
by previous work conducted with native rat BBOX (Spaniol et al.,
2001), and indicated the generation of several products. 1H and
13C NMR studies led to the identification of the hydrated form of
malonic acid semi-aldehyde 2 as a major product (Figure 4A).
The formation of 2, which decarboxylates to give acetaldehyde,
is consistent with amechanism involving oxidation at C-3 of THP
followed by N-N fragmentation to give a hydrolytically labile
imine. However, we did not observe production of 1,1,1-trime-
thylhydrazinium ions (or trimethylamine), as expected for a
‘‘simple’’ hydroxylation followed by fragmentation; instead, we
observed formation of dimethylamine. 2D NMR studies led to
the identification of formaldehyde (observed as a tris-(hydroxy-
methyl)aminomethane buffer adduct). The observation of HCHO
and dimethylamine, which must be produced by N-demethyla-
tion, provides a mechanistic link between BBOX/TMLH and the
histone N3-methyl lysine demethylases (Figure S3ii). The NMR
analyses also indicated the production of another initially unas-
signed product that was not observed with gBB. The combined
NMR data suggested the structure to be HO2CCH2CH(NH2)
CH2NCH3(CH2OH) 1. To support this assignment we prepared
THP 13C labeled at one of its N-methyl groups. The resultant
analyses confirmed the production of the previously assigned
products (formaldehyde and dimethylamine, with partial incor-
poration of 13C in the anticipated positions) and provided addi-
tional evidence for the formation of 1, with 13C being equally
distributed between the N-CH2 and the N-CH3 carbons (Figure 4;
Figure S4ii). Derivatization of the reaction mixture of labeled THP
followed by LC-MS analyses led to the isolation of the derivat-
ized product of 1, with partial incorporation of 13C in the ratios
anticipated (Figures 4D–4F).
DISCUSSION
BBOX and TMLH are closely related 2OG oxygenases belonging
to a distinct subfamily that is present in most eukaryotes and
many prokaryotes. BBOX is a homodimer mediated by its
N-terminal zinc-binding domain. The structural studies also
reveal the trimethylamino group-binding site of BBOX to be
related to those of histone-binding proteins. Following from
pioneering work on their roles in collagen biosynthesis, animal
2OG oxygenases have more recently been shown to play roles
in fatty acid metabolism, hypoxic sensing, and nucleic acid
modification. In addition to the inhibition of BBOX as a method
for cardioprotection, other human 2OG oxygenases are being
targeted for small molecule inhibition for the treatment of
diseases, including anemia and cancer. The structural informa-1320 Chemistry & Biology 17, 1316–1324, December 22, 2010 ª2010tion described here will be useful in order to develop potent
and selective inhibitors both of BBOX and other human 2OG
oxygenases.
Comparison of the structures of BBOX in complex with cofac-
tors, metal, and substrate or inhibitor presented here with that of
a recently published apo-BBOX structure provides a possible
explanation as to how substrates and products may enter and
leave the active site (Tars et al., 2010). The apo-BBOX structure
displays disordered loops surrounding the active site, indicating
that conformational flexibility of these regions in the absence of
substrate or inhibitor is possible. This suggests that an induced
fit mechanism may contribute to the catalytic activity of BBOX
and may explain the observation of limited accessibility to the
active site in the substrate inhibitor complexes.
The analog studies suggest that BBOX accepts a wide range
of substrates. In fact, when compared to generic 2OG oxygen-
ase inhibitors such as NOG and succinate (Table S1B, entries I
and III), these substrate analogs act as reasonably active
competitive inhibitors (Table S1B, entries IV–VII). The observa-
tion that BBOX has a less than stringent requirement for a trime-
thylammonium group may be useful for the design of improved
BBOX inhibitors.
In microorganisms and plants, 2OG oxygenases catalyze
a very wide range of oxidative reactions (Clifton et al., 2006;
Hausinger, 2004). However, to date, their reactions have been
limited to hydroxylations and N-demethylations via methyl group
hydroxylation in animals. We define the clinically used inhibitor
THP as being a competitive substrate for BBOX. THP undergoes
N-demethylation and N-N fragmentation leading to a C-C bond
forming rearrangement reaction. The closest parallel to the
conversion of THP to 1 in established organic reactions is the
Stevens rearrangement, wherein an ylide formed by deprotona-
tion of a quaternary amine undergoes rearrangement to give
a secondary amine via migration of one of the N-alkyl groups
(Figure S5) (Stevens, 1928; Vanecko et al., 2006). However, in
contrast to the harsh conditions of the Stevens rearrangement,
the BBOX catalyzed oxidative rearrangement of THP occurs in
aqueous solution at room temperature. We propose that the
BBOX-catalyzed reaction of THP involves initial reaction with
an iron-oxo intermediate (Krebs et al., 2007), as involved in other
2OG oxygenase reactions, to give a radical at C-3. In the case of
gBB, this can undergo a rebound process to give CAR (Fig-
ure 5A). However, with THP the presence of the secondary amine
enables fragmentation of the radical intermediate to give an
imine and a trimethylamine radical cation (Figure 5B). In the
case of THP, fragmentation of the radical must be faster than
hydroxylation because we did not observe Me3N
+NH2. In
support of the proposed role of the Aza group of THP in inducing
fragmentation, the THP analog in which the trimethylamino
group was replaced with t-butyl or isopropyl groups led to prod-
ucts resulting from ‘‘normal’’ hydroxylation, i.e., formation of
tert-butylamine or isopropylamine (Figure 5C; Table S1A, entries
VIII and IX). Following N-N cleavage, 1,2-hydrogen shift of the
trimethylamine radical cation gives a methylene radical that
can add into the imine to generate the rearranged C-C frame-
work (Figure 5D). Subsequent 1,5-hydrogen abstraction on one
of the N-methyl groups by the resultant amine radical (Fig-
ure 5D’), as precedented by the abstraction step in the Hof-
mann-Lo¨ffler-Freytag reaction (Curran et al., 1988), followed byElsevier Ltd All rights reserved
Figure 4. THP Reacts with BBOX in an Unprecedented Reaction
(A) Four products are observed in the THP reaction.
(B) 1D TOCSY of 1 confirming the four carbon chain. Selective excitation is applied on H-2 at 3.58 ppm.
(C) 2D HSQC showing the reaction of THP labeled with 13C on one of its methyl groups with BBOX. The 13C label (*) is transferred to 3 (1JCH = 143 Hz) and 4 (
1JCH =
160 Hz), and C-3, C-4 (1JCH = 141 Hz) and C-5 of 1, therefore confirming the formation of a new C-C bond. 2OG, succinate and Tris/Tris-
2H11 are observed at
natural abundance 13C levels. The 13C-labeled impurity was present in the starting material. 1 is shown as its formaldehyde adduct, on the basis of further NMR
analyses (Figure S4ii).
Reaction of BBOX with unlabeled THP (bottom row) or 13C-labeled THP (top row) with 6-N-aminoquinolyl-N-hydroxysuccinimidyl carbamate enabled the iden-
tification of the carbamoyl derivatives of: (D) dimethylamine 3 (m/z = 12C 216.1 and 13C 217.1);
(E) a singly derivatized product from 1 (m/z = 12C 303.1 and 13C 304.1), and (F) a doubly derivatized product derived from 1 (m/z = 12C 473.1 and 13C 474.1). In the
assay containing 13C-labeled THP, the isotope peak abundance is in accordance with the expected product ratio based on the proposed mechanism (Figure 5).
In the assay containing unlabeled THP, the isotope peak abundance reflects natural abundance levels.
See also Table S1 and Figure S4 BBOX product characterization.
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Figure 5. Mechanism for BBOX Catalysis
Proposed mechanisms for the reaction of gBB (route in A), THP (route in B), and 3-tert-butylamino propionic acid (route in C) with BBOX.
See also Figure S5 for the Stevens rearrangement mechanism.
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Crystal Structure of g-Butyrobetaine Hydroxylaserebound hydroxylation to give the rearranged product 1. Analysis
of the BBOX-THP structure is consistent with the proposed
mechanism; in particular one of the N-methyl groups of THP is
close to the metal (N-methyl C to Zn: 5.2 A˚ cf. C-3 of THP to
Zn: 4.7 A˚) (Me*) (Figure S3ii). The unprecedented nature of the
BBOX-catalyzed THP rearrangement further expands the scope
of reactions catalyzed by 2OG oxygenases and may inspire the
design of improved inhibitors for BBOX and other 2OG
oxygenases.SIGNIFICANCE
Carnitine plays an essential role in the metabolism of
many organisms by enabling transport of fatty acids into
mitochondria. Although produced endogenously in humans,
carnitine is also used in food supplements. The starting
material for carnitine biosynthesis is N3-trimethyllysine,
which is produced from the degradation of posttranslation-
ally modified proteins. Crystallographic studies of g-butyro-
betaine hydroxylase (BBOX), which catalyzes the final step
in carnitine biosynthesis, reveal how it binds to its
substrates and support prior kinetic analysis. They also
highlight structural links between BBOX and histone
demethylases, which also employ a ferrous iron cofactor
and 2OG and O2 co-substrates. The structural studies will
be useful in the design of improved BBOX inhibitors and
more selective inhibitors of other human 2OG oxygenases,
which are currently being targeted for therapeutic interven-
tion. Structural and mechanistic studies of the mode of
BBOX inhibition by the clinically used compound THP reveal
a rearrangement reaction for which there is no direct analog
in synthetic chemistry.1322 Chemistry & Biology 17, 1316–1324, December 22, 2010 ª2010EXPERIMENTAL PROCEDURES
Protein Production
The full-length gene of humanBBOX1was cloned into the pFastBac vector (In-
vitrogen) containing a tobacco etch virus (TEV) cleavable N-terminal hexahisti-
dine tag. Recombinant baculovirus was produced following themanufacturer’s
instructions (Invitrogen). HighFivecells (Invitrogen)weregrownas a suspension
in Sf-900 II medium supplementedwith 1% fetal calf serum (FCS) at 27C. Cells
were infected at a density of 2 3 106/ml with recombinant baculovirus (1 ml of
virus stock/1 liter of cell culture). Seventy-two hours after infection, the cultures
were collected and centrifuged (30 min, 2000 rpm, 4C). The cell pellet was re-
suspended in cold phosphate-buffered saline (PBS) and centrifuged as before.
The pellet from 1 liter of culture was then resuspended in 25 ml lysis buffer
(50 mMHEPES [pH 7.5], 500 mMNaCl, 5 mM imidazole, 5% glycerol 0.1% v/v
Igepal CA 630 (octylphenoxy)polyethoxyethanol, EDTA-free Complete Pro-
tease Inhibitor kit (Roche), benzonase (2.5 U/1 ml of a lysate), and 1 mM
TCEP tris(2-carboxyethyl)phosphine). Cells were lysed using a Dounce homog-
enizer, followed by centrifugation (45 min, 20, 000 rpm, 4C). The supernatant
was incubatedwith theNi-NTA resin for 1 hrwithgentlemixingat 4C.The resul-
tant resin suspensionwas loadedonagravity column, andafterwashingwith50
volumesof resinwithwashingbuffer containing50mMHEPES (pH7.5), 500mM
NaCl, 5%glycerol, and10mMimidazole, proteinwaselutedwith50mMHEPES
(pH 7.5), 500 mM NaCl, and 5% glycerol containing 250 mM imidazole buffer.
Fractions were analyzed by SDS-PAGE. Fractions containing BBOX were
combined. After EDTA treatment (final concentration 1 mM) at 4C to remove
excess Ni2+, the protein sample was applied to a Superdex 200 16/60 gel-filtra-
tion column, which had been equilibrated in 50 mM HEPES (pH 7.5), 500 mM
NaCl, 5% glycerol, and 1 mM TCEP. Fractions containing BBOX were com-
bined, and the N-terminal tag was removed by treatment with TEV protease
(o/n digestion at 4C). The protein was diluted with 25 mM Tris buffer (pH 8.0)
to 50 mM NaCl. The cleaved BBOX1, residual uncleaved BBOX1, and TEV
protease were separated on HiTrap Q Sepharose column, using NaCl gradient
(50–250mM). Fractions containing purified BBOXwere combined and concen-
trated using 30 kDa MWCO concentrator (Amicon).
Crystallization
Crystallization was performed in crystallization plates (SWISSCI, Zug,
Switzerland) in a 96-well (three subwell) format. A Mosquito (TTP Labtech)Elsevier Ltd All rights reserved
Table 1. Data Collection and Refinement Statistics
BBOX1: gBB (Hg SAD) BBOX:THP
Data Collection
Space group H32 H32
Cell dimensions
a, b, c (A˚) 107.39, 107.39,
204.92
107.37, 107.37,
205.05
a, b, g () 90, 90, 120 90, 90, 120
Resolution (A˚) (outer shell) 28.98–1.78
(1.88–1.78)
20–1.82
(1.92–1.82)
No. of molecules/ASU 1 1
No. of unique reflections 43,809 40,755
Completeness (%) 100.0 (100.0) 99.4 (96.2)
Redundancy 11.0 (10.7) 5.5 (5.3)
Rsym
a 0.140 (0.865) 0.083 (0.452)
Mean I/s (I) 12.3 (2.9) 12.3 (3.3)
Wilson B value (A˚2) 18.6 21.0
Phasing
Resolution (A˚) 28.82–1.78
Rcullis
b 0.846 (iso)/ 0.592 (ano)
Phasing power 0.909 (iso)/ 2.036 (ano)
Figure of merit
Centric 0.10831
Acentric 0.09341
After density modification 0.865
Refinement
Rfactor
c 0.14717 0.14671
Rfree
d 0.17633 0.18257
Rmsd
Bond length (A˚) 0.016 0.019
Bond angle () 1.554 1.600
No. of atoms
Protein 3192 3149
Ligand/ion 42 62
Water 437 413
<Bfactor > (A˚
2)
Protein 26.19 30.70
Ligand/ion 26.23 24.83
Water 28.79 31.46
Numbers in parentheses refer to the highest resolution shell.
a Rsym is the unweighted R value on I between symmetry mates.
bRcullis =
P
hkl jjFPH±FPj  FHðcalcÞj=
P
hkl jFPH±FPj.
c Rfactor =
P
hkl jjFobsj  kjFcalcjj=
P
hkl jFobsj for the working set of
reflections.
dRfree is the R value for 5% of the reflections excluded from refinement.
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screening and optimization of hits. The protein (20 mg/ml) was supplemented
with N-oxalylglycine (8 mM) and gBB or THP (4 mM) prior to crystallization.
Crystals were grown at 20C using the sitting drop vapor diffusion method
by mixing 100 nl of the protein solution and 50 nl of a precipitant solution
(0.2 M ammonium citrate [pH 7.0], 20% PEG 3350, 6% hexane-1,6-diamine,
and 10 mM ZnSO4). Crystals were flash cooled in liquid nitrogen using 25%
glycerol in mother liquor as a cryoprotectant.
A mercury derivative was prepared by incubating BBOX:gBB crystals for
60 min in a reservoir solution containing 10 mM thiomersal. Crystals wereChemistry & Biology 17, 1316–132then transferred for 1 min to a reservoir solution without mercury but supple-
mented with 25% ethylene glycol, and crystals were immediately flash frozen
in liquid nitrogen.
Data Collection and Processing
Data for BBOX crystals in complex with gBB and THP were collected at
DIAMOND beamline I02. Single-wavelength anomalous dispersion (SAD)
data using 1.0084 A˚ wavelength X-rays were collected at DIAMOND beamline
IO3 on a crystal derivatized with mercury. Data were integrated using XDS and
subsequently scaled using SCALA, whereas data of the mercury derivative
were integrated and scaled with the HKL2000 package (Table 1).
Crystallographic Phasing and Refinement
SHELXD was used to locate two mercury positions. Heavy atom positions
were refined, and initial phases were calculated with SHARP by using
a SIRAS method with the data of BBOX serving as the native data set. The
final electron density map after phase extension and solvent flattening
with SOLOMON was of excellent quality, and automated model building
with ARP/wARP resulted in a 95% complete model. Refinement of both
structures used REFMAC. After several rounds of manual rebuilding in
COOT and subsequent cycles of refinement, the models converged to a
final Rfactor/Rfree of 14.7%/17.6% and 14.6%/18.3% for BBOX:gBB and
BBOX:THP, respectively (Table 1).
Assays
NMR Assays
NMR experiments were conducted at 700 MHz using a Bruker Avance III
spectrometer equipped with an inverse TCI cryoprobe optimized for 1H obser-
vation and 3 mm diameter Bruker MATCHmicro tubes (Hilgenberg) containing
160 ml final sample volume. Solutions were buffered using Tris or Tris-2H11
(pH 7.5) dissolved 100%D2O or 95%H2O/5%D2O. Pulse tip-angle calibration
using the single-pulse nutation method was undertaken for each condition
using a blank assay sample . Reaction products are identified and assigned
by a combination of multiplicity edited HSQC, HMBC, 1D-TOCSY, and
COSY where applicable.
Kinetic Analyses
Standard kinetic assays were conducted at 298 K in solutions containing
12.5 nM BBOX, 50 mM Fe(II), 50 mM substrate, 1.5 mM 2OG, 5 mM ascorbate,
50 mM Tris-2H11 (pH 7.5), and 80 mM KCl. Reactions were started by the
addition of BBOX. Kinetic time courses were followed by using standard 1H
acquisition (ten transients with a relaxation delay of 1.2 s). The total time lapse
between addition of the enzyme and the end of the first acquisition was 4 min.
Time courses were followed for at least 15 min, and each measurement was
repeated at least three times.
Inhibition Assays
Inhibition assays were conducted at 298 K in solutions containing 12.5 nM
BBOX, 50 mM Fe(II), 50 mM gBB, 1.5 mM 2OG, 5 mM ascorbate, 50 mM
Tris-2H11 (pH 7.5), 80 mM KCl, and varying concentrations of inhibitor.
Reactions were initiated by BBOX addition. The extent of turnover of gBB to
give CAR was measured 3 min 45 s after mixing by using standard 1H
acquisition (ten transients with a relaxation delay of 1.2 s). Response curves
were fitted using OriginPro 8.0 (OriginLab, Northampton, MA, USA). Each
measurement was repeated at least three times.
MS Assays
MS experiments were conducted using a Waters LCT Premier XE (Waters,
Milford, MA, USA) and/or Bruker MicrOTOF. Assay conditions were as for
the NMR work, except that the solution was buffered in 100% H2O Tris-
2H11
(pH 7.5); quenching was by addition of 80% MeCN.
Derivatization Assay
The rearrangement product obtained by reacting THP and 13C-labeled THP in
the presence of BBOX was identified using the following procedure. Assay
conditions were as for the NMR work, and experiments were quenched by
addition of 10% MeCN. The samples were freeze-dried, and the mixture
was reacted in borate buffer with 6-N-aminoquinolyl-N-hydroxysuccinimidyl
carbamate according to the supplier’s instructions (Waters, Milford, MA,
USA), followed by MS analysis of the resulting mixture using a Waters LCT
Premier XE.4, December 22, 2010 ª2010 Elsevier Ltd All rights reserved 1323
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The structures have been deposited in the RCSB Protein Data Bank as ID
3MS5 and 3O2G.
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